Strengthen sharing, common win-win
Release time:
2021-09-22
Daye Peak encountered difficulties in research and development and innovation. Teachers were invited to give training and guidance from outside. Relevant personnel of Yunnan Peak also participated in the training through video connection. This is a very worthy practice. Although the problems involved in this training do not seem to be directly related to the current work needs of Yunnan peak, through this "lesson " , they have made relevant knowledge reserves in advance. if they encounter similar problems in the follow-up work, they can avoid detours. A simple "lesson " is just a simple effort, but it embodies the concept of resource sharing and resource efficiency maximization between brother units.
In our daily work, waste caused by the reuse of resources is not uncommon. Before the launch of ", 3, 3, 3, 3, 3, " , a subordinate enterprise often sent a car to go out to do business, while other departments had no car available only because they were a few minutes late, which not only delayed the work, but also caused a waste of management costs. Later, the problem was solved very simply. Before sending the car, ask other departments if they need it. If so, "" ". The importance of information and resource sharing can be seen from this.
In recent years, under the conscious guidance of the group company, cross-departmental and cross-enterprise exchanges have been strengthened, and there are also many cases worthy of recognition. For example, the construction of Anhui Xinbeika new project needs cable products, and an order has been placed for the cable company. Jianfeng Pharmacy takes advantage of its store sales network to focus on the promotion of Jianfeng Pharmaceutical and Jianfeng Health's independent products. Jianfeng Pharmaceutical watched the morning meeting of the cable company and learned from their good experience. Similar equipment "Package " needed in the technological transformation of cement enterprises will be invited for bidding together, the procurement cost is significantly reduced ... This Yunnan Jianfeng remote participation in the training of Daye Jianfeng is also a good example. Therefore, when we are doing things, we might as well think more divergent thinking, take the initiative "to think about " "to ask " to see if other departments and brother units have similar needs. Just a few words of communication can maximize the benefits of resources. Why not?
The sharing of information resources can improve work efficiency and the market competitiveness of enterprises. The higher the degree of internal resource sharing, the higher the value it can create. On the other hand, resource sharing can also effectively reduce waste, improve the utilization rate of resources, and promote the comprehensive development of enterprises. Therefore, as a group company, it is also advisable to give full play to the role of "Bridge " , make use of the advantages in grasping information and strategic direction, strengthen the connection and information sharing between various enterprises, shape the shared resource relationship between each other, and let the internal resource sharing play a greater role. Various departments usually communicate with other departments to strengthen the timely sharing of information, reduce unnecessary expenses and improve work efficiency; when enterprises obtain external resources, they share information and knowledge in a timely manner so that resources can be fully utilized to improve the overall competitive advantage of the group's enterprises and achieve a win-win situation. (Reporter Ni Yingzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page